• 1
    Connelly PW, Petrasovits A, Stachenko S, MacLean DR, Little JA, Chockalingam A. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group. Can J Cardiol 1999;15:428-433.
  • 2
    Marshall MC Jr. Diabetes in African Americans. Postgrad Med J 2005;81:734-740.
  • 3
    Zoratti R. A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin? Eur J Epidemiol 1998;14:9-21.
  • 4
    Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 2005;54:902-909.
  • 5
    Sattar N, Tan CE, Han TS, et al. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes Relat Metab Disord 1998;22:432-439.
  • 6
    WHO. Obesity: Preventing and Managing the Global Epidemic, Report of a WHO Consultation on Obesity. Geneva: World Health Organisation; 1998.
  • 7
    Miljkovic I, Zmuda JM. Epidemiology of myosteatosis. Curr Opin Clin Nutr Metab Care 2010;13:260-264.
  • 8
    Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 2003;284:E1065-E1071.
  • 9
    Miljkovic-Gacic I, Ferrell RE, Patrick AL, Kammerer CM, Bunker CH. Estimates of African, European and Native American ancestry in Afro-Caribbean men on the island of Tobago. Hum Hered 2005;60:129-133.
  • 10
    Bryc K, Auton A, Nelson MR, et al. Genome-wide patterns of population structure and admixture in West Africans and African Americans. Proc Natl Acad Sci USA 2010;107:786-791.
  • 11
    Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 2000;89:104-110.
  • 12
    Kosoy R, Nassir R, Tian C, et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum Mutat 2009;30:69-78.
  • 13
    Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-909.
  • 14
    Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 2003;10:186-191.
  • 15
    Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Am J Cardiol 2006;98:1363-1368.
  • 16
    Lin SX, Carnethon M, Szklo M, Bertoni A. Racial/ethnic differences in the association of triglycerides with other metabolic syndrome components: the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord 2011;9:35-40.
  • 17
    Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes 2008;33:239-248.
  • 18
    Toledo FG, Sniderman AD, Kelley DE. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 2006;29:1845-1850.
  • 19
    Durheim MT, Slentz CA, Bateman LA, Mabe SK, Kraus WE. Relationships between exercise-induced reductions in thigh intermuscular adipose tissue, changes in lipoprotein particle size, and visceral adiposity. Am J Physiol Endocrinol Metab 2008;295:E407-E412.
  • 20
    Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002;45:1201-1210.
  • 21
    Johnson JL, Slentz CA, Duscha BD, et al. Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis 2004;176:371-377.
  • 22
    Neutel JM. Metabolic manifestations of low-dose diuretics. Am J Med 1996;101:71S-82S.
  • 23
    Shen W, Punyanitya M, Chen J, et al. Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity (Silver Spring) 2006;14:727-736.
  • 24
    Stevens J, Gautman SP, Keil JE. Body mass index and fat patterning as correlates of lipids and hypertension in an elderly, biracial population. J Gerontol 1993;48:M249-M254.
  • 25
    Basu A, Tang H, Lewis CE, et al. Admixture mapping of quantitative trait loci for blood lipids in African-Americans. Hum Mol Genet 2009;18:2091-2098.
  • 26
    Chang MH, Ned RM, Hong Y, et al. Race/ethnic variation in the association of lipid-related genetic variants with blood lipids in the adult U.S. population. Circ Cardiovasc Genet 2011;4:523-533.
  • 27
    Kreisberg RA, Kasim S. Cholesterol metabolism and aging. Am J Med 1987;82:54-60.
  • 28
    Kolovou G, Bilianou H, Marvaki A, Mikhailidis DP. Aging men and lipids. Am J Mens Health 2011;5:152-165.
  • 29
    Rahilly-Tierney CR, Spiro A III, Vokonas P, Gaziano JM. Relation between high-density lipoprotein cholesterol and survival to age 85 years in men (from the VA normative aging study). Am J Cardiol 2011;107:1173-1177.
  • 30
    Rodriguez A, Muller DC, Metter EJ, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab 2007;92:3568-3572.
  • 31
    Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 2005;165:1395-1400.
  • 32
    McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-809.
  • 33
    Li C, Ford ES, Meng YX, Mokdad AH, Reaven GM. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 2008;7:4 (1-9).
  • 34
    Bovet P, Faeh D, Gabriel A, Tappy L. The prediction of insulin resistance with serum triglyceride and high-density lipoprotein cholesterol levels in an East African population. Arch Intern Med 2006;166:1236-1237.
  • 35
    Stern N, Grosskopf I, Shapira I, et al. Risk factor clustering in hypertensive patients: impact of the reports of NCEP-II and second joint task force on coronary prevention on JNC-VI guidelines. J Intern Med 2000;248:203-210.
  • 36
    Flesch M, Sachinidis A, Ko YD, Kraft K, Vetter H. Plasma lipids and lipoproteins and essential hypertension. Clin Investig 1994;72:944-950.
  • 37
    O'Connell BJ, Genest J Jr. High-density lipoproteins and endothelial function. Circulation 2001;104:1978-1983.
  • 38
    Durstine JL, Haskell WL. Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 1994;22:477-521.
  • 39
    Mukamal KJ, Mackey RH, Kuller LH, et al. Alcohol consumption and lipoprotein subclasses in older adults. J Clin Endocrinol Metab 2007;92:2559-2566.
  • 40
    De Oliveira ESER, Foster D, McGee Harper M, et al. Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 2000;102:2347-2352.